Psychosis and Schizophrenia

Schizophrenia is a chronic mental disorder that affects around 1% of the worldwide population. It causes psychotic behaviors, social and emotional disruptions and different cognitive impairments.

The causes of the disease are still not clear but studies show that both genetic and environmental factors have an effect on it.

Pain

pain is a very good target for therapeutic cannabinoids.

Prostate Cancer

Prostate cancer is the development of cancer in the prostate.

Glioblastoma

Glioblastoma is a malignant brain tumor originated in brain cells called astrocytes. Glioblastoma is one of the most promising targets for Cannabinoid therapy. Several research groups found anti-tumor properties of cannabinoids in vitro and in vivo studies.

Cervical cancer

Cervical Cancer is a type of cancer that develops from the cervix.

Breast cancer

Breast cancers develop from breast tissue. cannabinoids have anti Breast Cancer properties involving inhibition of cancer growth and metastasis.

Cancer

In spite of the increasing scientific interest to understand how cannabinoids can help to treat cancer disease, symptoms and the associated chemotherapy side effects, the existing scientific evidence is not enough to satisfy the clinical criteria to consider cannabinoids as a part of the treatment.

Parkinson's

Parkinson's Disease is a degenerative disorder of the nervous system marked by accelerated degeneration of dopamine-producing neurons in the Substantia Nigra in the brain.

Typical symptoms of Parkinson's Disease , such as (intentional) tremor, rigidity and slowness of movement are mostly ascribed to degenerating Substantia Nigra neurons.

Alzheimer's disease

Alzheimer’s disease is a chronic neurodegenerative disease and the main cause of dementia. Main common symptoms of dementia are related with memory but other cognitive processes are affected during the development of the disease.

ADHD

ADHD is a neurodevelopmental disorder that is characterised by loss of attention and impulsive behaviour.